Literature DB >> 10712163

Immunophilin ligands as a novel treatment of neurological disorders.

T Herdegan1, G Fischer, B G Bold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10712163     DOI： 10.1016/s0165-6147(99)01407-8

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  4 in total

1.  Design and structure-based study of new potential FKBP12 inhibitors.

Authors:  Fei Sun; Pengyun Li; Yi Ding; Liwei Wang; Mark Bartlam; Cuilin Shu; Beifen Shen; Hualiang Jiang; Song Li; Zihe Rao
Journal:  Biophys J       Date:  2003-11       Impact factor: 4.033

2.  The immunophilin-ligands FK506 and V-10,367 mediate neuroprotection by the heat shock response.

Authors:  Alexa Klettner; Thomas Herdegen
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

3.  Molecular basis of anti-apoptotic effect of immunophilin ligands on hydrogen peroxide-induced apoptosis in human glioma cells.

Authors:  Ken-ichi Tanaka; Masato Asanuma; Norio Ogawa
Journal:  Neurochem Res       Date:  2004-08       Impact factor: 3.996

4.  Structure-affinity properties of a high-affinity ligand of FKBP12 studied by molecular simulations of a binding intermediate.

Authors:  Lilian Olivieri; Fabrice Gardebien
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.